CEACAM5 and neoplasm: Comparing the levels of blood-derived traditional tumor markers, CA125 (p < 0.001), CA19-9 (p = 0.014), CA15-3 (p < 0.001), CEA (p = 0.003), LDH (p = 0.004), and procalcitonin (p = 0.031) as well as FAR (p < 0.001), distinguishes benign cases from malignant.